Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical islet transplantation.

Dixon B Kaufman1, William L Lowe

  • 1Feinberg School of Medicine, Northwestern University, Galter Pavilion, #17-200, 675 N. St. Clair Street, Chicago, IL 60611, USA. d-kaufman2@northwestern.edu

Current Diabetes Reports
|July 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-ancestry, trans-generational GWAS meta-analysis of gestational diabetes and glycaemic traits during pregnancy reveals limited evidence of pregnancy-specific genetic effects.

Nature communications·2026
Same author

Maternal BMI associations with cord blood DNA methylation and mid-childhood adiposity.

Clinical epigenetics·2026
Same author

Associations of umbilical cord vitamin D levels with childhood cardiometabolic risks: a longitudinal mother-child study.

Frontiers in nutrition·2026
Same author

Examining the association between fetal HLA-C, maternal KIR haplotypes and birth weight.

PLoS genetics·2026
Same author

Evaluating ancestry adjustment in multi-ancestry epigenome-wide analysis.

Epigenetics·2026
Same author

The contribution of maternal glucose to birth weight is smaller in Uganda (sub-Saharan Africa) than in Afro-Caribbean or white ethnicity mother-child pairs from outside Africa.

BMJ global health·2026
Same journal

Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness.

Current diabetes reports·2026
Same journal

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease.

Current diabetes reports·2026
Same journal

Climate Change and Diabetes Outcomes: Evidence from Climate-Vulnerable Regions.

Current diabetes reports·2026
Same journal

Efficacy and safety of once-weekly basal insulin analogs versus daily basal insulin analogs in adults with type 2 diabetes: a systematic review and meta-analysis.

Current diabetes reports·2026
Same journal

Use of Glucagon-Like Peptide-1 Receptor Agonists in Women with Type 2 Diabetes Before Pregnancy: Addressing the Dilemma in A Real-World Setting.

Current diabetes reports·2026
Same journal

Can Behavioral Interventions Promote Health Equity in Pediatric Type 1 Diabetes? A Narrative Review of Promising Treatments.

Current diabetes reports·2026
See all related articles

Type 1 diabetes treatment using islet transplantation shows promise for eliminating insulin dependence. Overcoming donor tissue shortages and reducing immunosuppression are key to wider application.

Area of Science:

  • Endocrinology
  • Transplantation Immunology
  • Metabolic Diseases

Background:

  • Type 1 diabetes impacts over 1 million individuals in the U.S., with 30,000+ new diagnoses yearly.
  • Pancreas or islet transplantation can cure Type 1 diabetes by restoring insulin production.
  • Islet transplantation offers a minimally invasive approach with potential for broader patient access.

Purpose of the Study:

  • To evaluate the efficacy of islet transplantation as a treatment for Type 1 diabetes.
  • To identify challenges and future directions for scaling up islet transplantation therapy.

Main Methods:

  • Review of current clinical experiences and outcomes of islet transplantation.
  • Analysis of factors limiting the widespread application of this therapy.

Related Experiment Videos

Main Results:

  • Early clinical data confirm islet transplantation as an effective strategy for select Type 1 diabetes patients.
  • Successful transplantation normalizes glycosylated hemoglobin and eliminates the need for exogenous insulin.

Conclusions:

  • Islet transplantation is a viable therapeutic option for Type 1 diabetes.
  • Addressing donor tissue scarcity and minimizing long-term immunosuppression are critical for expanding this treatment.